2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2007080967v1 19/11/2077    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Zheng, S. Articles by Epstein, P. N. PubMed PubMed Citation Articles by Zheng, S. Articles by Epstein, P. N. Related Collections Related Articles

Podocyte-Specific Overexpression of the Antioxidant Metallothionein Reduces Diabetic Nephropathy

Shirong Zheng^*,, Edward C. Carlson, Lu Yang^*, Patricia M. Kralik^*, Yun Huang^* and Paul N. Epstein^*

^* Department of Pediatrics, Institute for Cellular Therapeutics, Department of Surgery, University of Louisville, Louisville, Kentucky; and Department of Anatomy, University of North Dakota, Grand Forks, North Dakota

Correspondence: Dr. Paul N. Epstein, 570 South Preston Street, Department of Pediatrics, University of Louisville, Louisville, KY 40202. Phone: 502-852-2655; Fax: 502-852-5634; E-mail: paul.epstein{at}louisville.edu

Received for publication August 31, 2007. Accepted for publication May 15, 2008.

Podocytes are critical components of the selective filtration barrier of the glomerulus and are susceptible to oxidative damage. For investigation of the role of oxidative stress and podocyte damage in diabetic nephropathy, transgenic mice that overexpress the antioxidant protein metallothionein (MT) specifically in podocytes (Nmt mice) were produced. MT expression was increased six- and 18-fold in glomeruli of two independent lines of Nmt mice, and podocyte-specific overexpression was confirmed. Glomerular morphology and urinary albumin excretion were normal in Nmt mice. OVE26 transgenic mice, a previously reported model of diabetic nephropathy, were crossed with Nmt mice to determine whether an antioxidant transgene targeted to podocytes could reduce diabetic nephropathy. Double-transgenic OVE26Nmt mice developed diabetes similar to OVE26 mice, but MT overexpression reduced podocyte damage, indicated by more podocytes, less glomerular cell death, and higher density of podocyte foot processes. In addition, expansion of glomerular and mesangial volume were significantly less in OVE26Nmt mice compared with OVE26 mice. Four-month-old OVE26Nmt mice had a 70 to 90% reduction in 24-h albumin excretion, but this protection does not seem to be permanent. These results provide evidence for the role of oxidative damage to the podocyte in diabetic mice and show that protection of the podocyte can reduce or delay primary features of diabetic nephropathy.

Related Articles

This Month's Highlights
J. Am. Soc. Nephrol. 2008 19: A10. [Full Text] [PDF]

This article has been cited by other articles:

				R. F. Spurney and T. M. Coffman Stressed-out Podocytes in Diabetes? J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2035 - 2037. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673